Global Diagnostics Partnering Terms and Agreements 2014-2021


The Global Diagnostics Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Publication date
May 2021
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

The Global Diagnostics Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading companies.


  • Comprehensive directory of diagnostic deals since 2014
  • Diagnostic contract documents
  • Diagnostic agreement terms
  • Diagnostic agreement structure
  • Top diagnostic deals by value
  • Most active diagnostic dealmakers


This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: 


  • Companion Diagnostics
  • Imaging
  • CT
  • Endoscope
  • Molecular and nuclear
  • MRI
  • Ultrasound
  • X-ray
  • PET
  • Angiography
  • Fluroscopy
  • Mammography
  • In vitro diagnostics
  • Molecular diagnostics
  • Prognostics
  • Theranostics


The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.


This report provides details of the latest Diagnostics agreements announced in the life sciences since 2014.


The report takes the reader through a comprehensive review Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Diagnostics partnering deals.


The report presents financial deal term values for Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the Diagnostics partnering field; both the leading deal values and most active Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 3,000 online deal records of actual Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Diagnostics dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading Diagnostics deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 25 most active companies in Diagnostics dealmaking with a brief summary followed by a comprehensive listing of Diagnostics deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of Diagnostics partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of Diagnostics partnering deals signed and announced since Jan 2014. The chapter is organized by specific Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in Diagnostics partnering and dealmaking since 2014.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Diagnostics technologies and products.


Key benefits


Global Diagnostics Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:


  • In-depth understanding of Diagnostics deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Diagnostics contracts entered into by leading biopharma companies
  • Identify most active Diagnostics dealmakers since 2014
  • Insight into terms included in a Diagnostics partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Diagnostics Partnering Terms and Agreements 2014-2021 is intended to provide the reader with an in-depth understanding and access to Diagnostics trends and structure of deals entered into by leading companies worldwide.


Diagnostics Partnering Terms and Agreements includes:


  • Trends in Diagnostics dealmaking in the biopharma industry since 2014
  • Analysis of Diagnostics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to Diagnostics contract documents
  • Leading Diagnostics deals by value since 2014
  • Most active Diagnostics dealmakers since 2014


In Global Diagnostics Partnering Terms and Agreements 2014-2021, the available deals are listed by:


  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Diagnostics Partnering Terms and Agreements 2014-2021 report provides comprehensive access to available deals and contract documents for over 3,000 Diagnostics deals.


Analyzing actual contract agreements allows assessment of the following:


  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Diagnostics Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:


  • In-depth understanding of Diagnostics deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Diagnostics contracts entered into by leading biopharma companies
  • Identify most active Diagnostics dealmakers since 2014
  • Insight into terms included in a Diagnostics partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in Diagnostics dealmaking


2.1. Introduction

2.2. Diagnostics partnering over the years

2.3. Most active Diagnostics dealmakers

2.4. Diagnostics partnering by deal type

2.5. Diagnostics partnering by therapy area

2.6. Deal terms for Diagnostics partnering

2.6.1 Diagnostics partnering headline values

2.6.2 Diagnostics deal upfront payments7

2.6.3 Diagnostics deal milestone payments

2.6.4 Diagnostics royalty rates


Chapter 3 – Leading Diagnostics deals


3.1. Introduction

3.2. Top Diagnostics deals by value


Chapter 4 – Most active Diagnostics dealmakers


4.1. Introduction

4.2. Most active Diagnostics dealmakers

4.3. Most active Diagnostics partnering company profiles


Chapter 5 – Diagnostics contracts dealmaking directory


5.1. Introduction

5.2. Diagnostics contracts dealmaking directory


Chapter 6 – Diagnostics dealmaking by technology type


Chapter 7 – Partnering resource center


7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking




Appendix 1 – Diagnostics deals by company A-Z


Appendix 2 – Diagnostics deals by stage of development




Phase I

Phase II

Phase III





Appendix 3 – Diagnostics deals by deal type

Asset purchase


Bigpharma outlicensing


Collaborative R&D







Equity purchase



Joint venture





Material transfer





Spin out



Technology transfer




Appendix 4 – Diagnostics deals by therapy area


Appendix 5 –Deal type definitions


About Wildwood Ventures


Current Partnering

Current Agreements

Recent report titles from Current Partnering


Table of figures

Figure 1: Diagnostics partnering since 2014

Figure 2: Active Diagnostics dealmaking activity since 2014

Figure 3: Diagnostics partnering by deal type since 2014

Figure 4: Diagnostics partnering by disease type since 2014

Figure 5: Diagnostics deals with a headline value

Figure 6: Diagnostics deals with an upfront value

Figure 7: Diagnostics deals with a milestone value

Figure 8: Diagnostics deals with a royalty rate value

Figure 9: Top Diagnostics deals by value since 2014

Figure 10: Most active Diagnostics dealmakers since 2014

Figure 11: Online partnering resources

Figure 12: Forthcoming partnering events

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license


A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers., 2bPrecise, 2cureX, 3D BioMed, 3Derm Systems, 3DR Labs, 3D Signatures, 3M, 3PrimeDx, 4D Molecular Therapeutics, 4D Path, 5-Diagnostics, 7D Surgical, 10X Genomics, 14M Genomics, 20/20 GeneSystems, 23andMe, 36 Strategies General Trading, 1717 Life Science Ventures, A*STAR Agency for Science, Technology and Research, A*STAR Institute of Microelectronics (IME), A2 Biotherapeutics, AAM Healthcare, AB Analitica, Abaxis, Abbott Laboratories, Abbott Rapid Diagnostics, Abbvie, Abcam, Abcodia, Abionic, Abramson Cancer Center, Acacia Research, Accelerate Diagnostics, Accelerate Technologies, Access BIO, Accudata Systems, AccuGenomics, Accurate Diagnostic Laboratories, Accuray, AccuRef Diagnostics, Accu Reference Medical Laboratory, Accuscience, AceCGT Life Science, Achaogen, AC Immune, ACIST Medical Systems, Acon Labs, Acoustic MedSystems, Actelion, ACT Genomics, Acumen Pharmaceuticals, Acupath Laboratories, Acutus Medical, AdAlta, Adaptiiv, Adaptive Biotechnologies, Adaptive Phage Therapeutics, ADC Therapeutics, Adeptrix, Adial Pharmaceuticals, Aditx Therapeutics, ADMA Biologics, Admera Health, ADS, ADT Altona Diagnostic Technologies, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced Biological Laboratories, Advanced Cell Diagnostics, Advanced Chemistry Development, Advanced Cooling Therapy, Advanced Dermatology and Cosmetic Surgery Group, Advanced Genomic Solutions, Advanced Guidance Technologies, Advanced Medical German Company of Kuwait, Advanced Nuclear Medicine Ingredients, Advanced Ultrasound Systems, ADx Healthcare, Aegea Biotechnologies, Aelan Cell Technologies, Aerocrine, AEterna Zentaris, Aethlon Medical, Aetna, Affinium Pharmaceuticals, AFFiRiS, Affymetrix, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, Agappe, Age Labs, Agena Bioscience, Agendia, Agfa HealthCare, Agilent Technologies, Agiomix FZ, Agios Pharmaceuticals, AG Mednet, Agricultural Research Service, AID Genomics, Aidoc, Aiforia Technologies, AI Metrics, AIM Specialty Health, Aircraft Medical, Air Force General Hospital, Air Force Research Laboratory, AirStrip Technologies, AIT Laboratories, Akers Biosciences, Akili Interactive Labs, Ako Med, Akonni Biosystems, Akoya Biosciences, Akribis Systems, AKSA Medical, Alab, Albany Molecular Research, Albert Einstein Healthcare Network, Albertsons Companies, Alcanna, Aldeyra Therapeutics, Alector, Alere, Aleris, Alexion Pharmaceuticals, Alfasigma, Algenex, AlgoMedica, Alibaba Health, Align Technology, AliveCor, ALK-Abello, Allakos, Allegheny Technologies, Allele Biotechnology and Pharmaceuticals, Allergan, AllerGenis, Alliance Global FZ, Alliance Global Group, Alliance Pharma, Allied Healthcare Products, Almac Diagnostics, Almac Group, Alnylam Pharmaceuticals, Alpha-Tec Systems, Alphaeon, Alphageneron Pharmaceuticals, Alpha Imaging, Alphazyme, Alpinion Medical Systems, ALR Technologies, AltaML, Alteris, Altris, Alume Biosciences, Alveo Technologies, Alverno Clinical Laboratories, Al Zahrawi Medical Supplies, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Alzheimers Research UK, Amarantus BioSciences, Amazon Web Services, Ambra Health, Ambry Genetics, Ambu, AmCad BioMed, AMD Insight, A Menarini Diagnostics, America's Choice Provider Network, American Animal Hospital Association, American College of Cardiology, American College of Chest Physicians, American Diabetes Association, American Health Imaging, American Lung Association, American Medical Depot, American Medical Systems, American Pathology Partners, Amerinet, Amgen, Amos Gazit, Amoy Diagnostics, Amplitech, AmpTec, AMRA, AMRA Medical, AMS, Amydis Diagnostics, Analog Devices, Analogic, Analytics 4 Life, Analytics Engines, Anapure BioScientific, Anavex Life Sciences, AnchorDx, Angle, Angsana Molecular & Diagnostics, Anika Therapeutics, Anixa Biosciences, Annar Health Technologies, Annoroad, Anpac Bio-Medical Science, ANP Technologies, Antaros Medical, Antech, Anteo Diagnostics, AnteoTech, Anthem, Anthem Bluecross, Apax Partners, Aperiomics, Apogenix, Apollo Med Innovations, Appistry, Apple, Applied BioCode, Applied DNA Sciences, Applied Medical, Appriss Health, APRINOIA Therapeutics, Aptagen, Aptar Pharma, Aptorum Group, Arbor Biosciences, Arbor Vita, ArcDia, ArcherDX, Arches Research, ARCHIMEDlife, Arc Medical Design, ArcticDx, Ares Genetics, Ares Life Sciences, Areva Med, Aridea Solutions, Ariosa Diagnostics, Arisan Therapeutics, Arivis, Arizona State University, Arkansas Childrens Hospital, Arkray, Arkray USA, Armed Forces Medical Research Institute, Arno Therapeutics (inactive since 2017), AroCell, Arquer Diagnostics, Array Biopharma, Arrow Diagnostics, Arterial Health International, Arteriomed, Artialis, Artificial, ARTMS Product, ARUP Laboratories, Asahi Kasei, Ascensia Diabetes Care, Ashion Analytics, Ashvattha Therapeutics, Asieris MediTech, Aspect Imaging, Aspen Imaging Healthcare, ASPiRA Labs, Aspira Scientific, Assistance Publique-Hôpitaux de Paris, Association for Frontotemporal Degeneration, Astarte Medical, Astellas Pharma, Asterand Bioscience, Asthma UK, Astra Formedic, AstraZeneca, AstraZeneca HealthCare Foundation, Astute Medical, Asuragen, AsureQuality, AtCor Medical, ATGen Global, Athinoula A Martinos Center for Biomedical Imaging, Athletigen, Atlas Genetics, Atlas Genomics, Atomo Diagnostics, Atreca, Atrin Pharmaceuticals, Atrys Health, Aurora Diagnostics, Aurum Ventures, Austin Health, Austrian Institute of Technology, Autism Learning Partners, Autobio Diagnostics, AutoGenomics, AUT Roche Diagnostics Laboratory, AUT University, Auxogyn, Avacta, Avalon GloboCare, Avant Diagnostics, Avantis Medical Systems, Avellino Labs, AVEO Oncology, Avera Heart Hospital of South Dakota, Avicenna Technology, Aviir Diagnostics, AVL Sofia, Avricore Health, Avrobio, Avrok Laboratories, Axela, Axella Research, Axia Women's Health, Axil Scientific, AXIM Biotechnologies, Axonlab, AyoxxA Biosystems, Aytu BioPharma, Babson Diagnostics, Baebies, Baker IDI Heart and Diabetes Institute, BAMF Health, Banc De Sang I Teixits, Banner Health, Banyan Biomarkers, Bardy Diagnostics, Barnabas Health, BASE10 Genetics, BASF, BATM, Battelle, Baxter International, Bay Area Lyme Foundation, Bayer, Bayer Healthcare, Bay Labs, Baylor College of Medicine, Baylor Genetics, Baylor Miraca Genetics Laboratories, BBI Diagnostic, BBI Solutions, B Braun, B Braun CeGaT, BC Neuroimmunology, BC Platforms, BC Technical, BD Biosciences, BEAM Diagnostics, Beckman Coulter, Be Creative Lab, Becton Dickinson, BeiGene, Beijing Clear Biotech, Beijing Emei Tongde Technology Development, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Beijing Leadman Biochemistry, Beijing Yuan Jian Health Management, BeMotion, Benchmark Electronics, Berg, Beroni Group, Berry Genomics, Bertech Diagnostics, Bertin Pharma, Bestbion, Bestmed, Best Supplies, Be The Match BioTherapies, Bethyl Laboratories, Better Living Now, Beurer, Beyond Batten Disease Foundation, Beyondspring Pharmaceuticals, BHR Pharma, Bill and Melinda Gates Foundation, BillionToOne, Binx Health, Bio-Manguinhos, Bio-Me, Bio-Rad Laboratories, Bio-Techne, bioAffinity Technologies, BioAnalytical Systems, BioArctic Neuroscience, BIOASTER, BioCanna Healthcare, Biocare Medical, Biocartis, Biocept, BioChain, BioCheck, BioClinica, Biocom Purchasing Group, bioCSL, Biodesix, Biodirection, BioDiscovery, Biodist, Biofidelity, BioFire Diagnostics, Biofourmis, BioGemex, Biogen, BIOgenetiX, BioGen Medical, Biognosys, BioGX, Biohealth Innovation, Biohit, Biohit Healthcare, Bioiatriki, BioInvent, BioIQ, Biokit, BioLab Sciences, Biolidics, Biolife Science, BioLight Life Sciences Investments, BioLizard, Biological Dynamics, BioMarin Pharmaceutical, BioMark Diagnostics, BioMarker Strategies, Biomatrica, Biomecite Diagnostics, Biomedical Advanced Research and Development Authority, Biomedica Medizinprodukte, Biomedix, BIOMEDX Group, BioMed X Innovation Center, Biomeme, Biomerica, bioMerieux, Biomillenia, Biomnis, BioNano Genomics, BioNova Cientifica, BioNTech, Bioo Scientific, BiopharmX, BioPorto, Bioportugal Quimica Farmaceutica, Biopsy Sciences, Bioptic, BioReference Laboratories, Bioscience Pharma Partners, Biosearch Technologies, BioSensics, BioSkryb, BioSure, BioSymetrics, Biosynex, BioSyntagma, Biotage, Biotech-IgG, Biotechnology Innovation Organization, BioTecon Diagnostics, BioTelemetry, BioTheranostics, bioTRADING Benelux, Biotronik, BioVaxys, BioVendor, Bioventix, Bioverativ, Biovica, Bioyong, Biozym Scientific, Bird Foundation, BJC HealthCare, BKare Diagnostics, BL&H, Blackford, Blackrock NeuroMed, Black Swan Research Initiative, Blanchette Rockefeller Neurosciences Institute, Blinktbi, Bliss Biopharmaceutical, BloodCenter Of Wisconsin, Blood Centers of America, Blood Systems Research Institute, Bluebee, Blue Cross Blue Shield Association, BlueCross BlueShield of Tennessee, Blue Earth Diagnostics, Bluejay Diagnostics, Blueprint Genetics, Blueprint Medicines, BluSense Diagnostics, BMV Medica, BND, Bode Technology, Boditech Med, BodyCheck, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bonnie J. Addario Lung Cancer Foundation, Boreal Genomics, Bosch, BostonGene, Boston IVF, Boston Medical Center, Boston Scientific, Boston University, Boston University School of Medicine, Bostwick Laboratories, Bpifrance, Bracco Diagnostics, Bracco Imaging, Brahms, BRAINBox Solutions, BRAIN Initiative, BrainLAB, Brainomix, BrainScope, BrainStem Biometrics, Brandeis University, Branhaven, Breakthrough Diagnostics, Breath Diagnostics, BreathTech, BrickBio, BridgeCrest Medical, Brigham and Women's Hospital, Brigham Young University, Brik, Bristol-Myers Squibb, Bristol-Myers Squibb Pakistan, BroadcastMed, Broad Institute, Bruker, Bruker AXS, Bruker Energy & Supercon Technologies (BEST), Buck Institute for Age Research, BullFrog AI, Burkhan Group, Burnet Institute, Burning Rock, Butantan Institute, Butterfly Network, BWX Technologies, C&C Irradiator Service, C2i Genomics, C2N Diagnostics, C4 Imaging, Cadila Pharmaceuticals, Calcivis, Caliber Imaging & Diagnostics, Calviri, Cambridge Bioscience, Cambridge Blockchain, Cambridge Clinical Laboratories, Cambridge Cognition, Cambridge Consultants, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Isotope Laboratories, Canabo Medical Clinics, Canadian Pathology Quality Assurance, Canadian Teleradiology Services, Canary Health Technologies, CANbridge Life Sciences, Cancer Genetics, Cancer Prevention and Research Institute of Texas, Cancer Research Institute, Cancer Research UK, Cancer Targeted Technology, Canon, Canon BioMedical, Canon Lifecare Solutions, Canon U.S. Life Sciences, Cantel Medical, Capital X-ray, Capnia, Caprion Proteomics, CapsoVision, Capsulomics, Caputron Medical, CARB-X, Cardiff University, Cardinal Health, CardiNor, CardioCORE Lab, CardioDx, CardioLogic, Cardiologs, CardioNavix, Cardiorentis, Cardiowise, Cardurion Pharmaceuticals, CareDx, CareFirst BlueCross BlueShield, CareFusion, Care GB Plus, Carestream Health, Cargill, Caris Life Sciences, Carlos Slim Health Institute, Carl Zeiss, Carl Zeiss Meditec, Carmentix, Carpegen, CarThera, Case Western Reserve University, CAS Medical Systems, Catholic University Leuven, CBD Solutions, CBD Vida, CBLPath, CDC Foundation, CDx Diagnostics, CeGaT, Celcuity, Celgene, Cellex, Cellgen Diagnostics, Cell Guidance Systems, Cell Marque, CellMax Life, Cellmic, Cellnetix, CellSafe, CellSight Technologies, Cell Signaling Technology, Celmatix, Celsee, Celsion, Celsius Therapeutics, Celtic Biotech, Celularity, Cenetron, Cenix BioScience, Censis Technologies, Centaur, Centene, Center for Advancing Point of Care Technologies, Center for Connected Health, Center for Diagnostic Imaging (CDI), Center for Human Genetics and Laboratory Medicine, Center for Human Immunology, Autoimmunity and Inflammation, Centerline Biomedical, Centers for Disease Control and Prevention, Centogene, Centre for Addiction and Mental Health, Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre for Structural Systems Biology, Centre Hospital University - Bordeaux, Centre Leon Berard, Centre National de la Recherche Scientifique, Cepheid, Cerba HealthCare, CerebraCell, CereHealth, Ceres, Cerevast Therapeutics, CERIMED, Cernostics, Certainty Health, Cerveau Technologies, Champalimaud Foundation, Change Healthcare, Charles River Laboratories, CHDI Foundation, Check-Cap, Chek Diagnostics, Chembio Diagnostics, Chemie Brunschwig, ChemImage, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Orange County, Children's Hospital of Philadelphia, Children's Hospital of Pittsburgh Foundation, Children's Hospital Of Wisconsin, Children's National Health System, Children’s Hospital Colorado, Children’s Hospital Oakland Research Institute (CHORI), China Biotech Services, China Development Industrial Bank, China Grand Pharma, China Grand Pharmaceutical, Chindex Medical Limited, Chinese Center for Disease Control and Prevention, Chinese University of Hong Kong, Chip-Man Technologies, Christian Doppler Research Association, Chronix Biomedical, Chugai Pharmaceutical, Chun Fo Pharmaceutical, Cicero Diagnostics, Cimar, Cincinnati Children’s Hospital Medical Center, Cipla, CIRCA Scientific, Circulogene, Cirrus Dx, City of Hope, Clarient, Claritas Genomics, Claritas HealthTech, Clarity Pharmaceuticals, Clearbridge Biomedics, Cleared4, Clear Guide Medical, ClearLight Diagnostics, ClearView Diagnostics, Cleveland Clinic, Cleveland Diagnostics, Cleveland HeartLab, Clevexel Pharma, Client Outlook, Clinatec, Clinical Genomics, Clinical Imaging Research Centre, Clinical Laboratory Partners, Clinical Reference Laboratory, Clinica Ruiz, Clinic for Special Children, Clinipace Worldwide, CliniSciences, Clinton Health Access Initiative, CloudHealth Genomics, Cloud Pharmaceuticals, Clovis Oncology, CNC Biotech, CND Life Sciences, CNS Pharmaceuticals, Co-Diagnostics, CoaChrom Diagnostica, Coala Life, Cobalt Healthcare Consultants, Codexis, Cofactor Genomics, Cognetivity Neurosciences, Cognoa, CogState, Cohen Veterans Bioscience, Cold Spring Harbor, Collective Medical, Colorado State University, Color Genomics, Columbia University, Columbia University Medical Center, Comanche County Memorial Hospital, CombiMatrix, Common Sense, Commonwealth Laboratories, Community Medical Center, Compact Imaging, CompanionDx Reference Lab, Companion Medical, Compumedics, Conavi Medical, ConBio (Shanghai), Concert Genetics, Concile, Confirm BioSciences, Confo Therapeutics, Congenica, Connecticut Innovations, Consilient Health, Contextual Genomics, ContextVision, ContraVir Pharmaceuticals, Control Flo Medical, Cook Medical, COPAN, Copan Diagnostics, Copenhagen University Hospital, CoreBiome, Core Diagnostics India, Corgenix Medical, Coriell Life Sciences, Cornell University, Corona Diagnostics, CorTechs Labs, Cortexyme, Corvida Medical, Corvium, Cosmo Bio, Cosmo Pharmaceuticals, COTA, Courtagen Life Sciences, Covance, Covidien, CPR Pharma Services, CPT Medical, CQuentia, Creoptix, CR Kennedy & Company, Crohn's and Colitis Foundation of America, CrossBay Medical, Crossbeta Biosciences, CrowdMed, Crown Bioscience, Crown Dental + Medical, Cryopep, CSI Laboratories, CSIRO, CS Medical, CStone Pharmaceuticals, Cubist Pharmaceuticals, Cue Health, Curative, Cure Brain Cancer Foundation, Cure Duchenne, Cure Forward, CureMetrix, Curetis, Curium, CurveBeam, CyberKnife, Cyclenium Pharma, Cyclerion Therapeutics, Cyclopharm, Cyient, CymaBay Therapeutics, Cynvenio, Cypher Genomics, Cypre, Cytiva, CytoLumina Technologies, Cytox, D&K Technologies, D-Eye, d3 Medicine, Dacadoo, Daiichi Sankyo, Dako, Daktari Diagnostics, Dana-Farber Cancer Institute, Danish Center for Strategic Research into Type 2 Diabetes, DarioHealth, Dartmouth-Hitchcock Medical Center, DaRui Biotech, DarwinHealth, DASA, DATANet Software Development, DaVita HealthCare Partners, Daxor, DCN Diagnostics, DDL Diagnostic Laboratory, Debiopharm, Decathlon Capital Partners, DeciBio Consulting, Decipher Biosciences, Deciphex, Decision Diagnostics, deCODE Genetics, Dectris, Deep Cube, Defense Advanced Research Projects Agency, Defense Logistics Agency, Defense Threat Reduction Agency, Definiens, Dehaier Medical Systems, Dell, Dell Medical School, Deltex Medical, Denali Therapeutics, Dendreon, Densitas, Department of Defence, Department of Defense, Department of Health and Human Services, Department of Homeland Security, Department of Veterans Affairs, DePuy, Dermpath Diagnostics, DermSpectra, DermTech, Desert Imaging, DestiNA Genomics, Deutsches Elektronen-Synchrotron, Device Technologies, Devicor Medical Products, DexCom, Diabetes Singapore, DiaCarta, Diaceutics, diaDexus, Diagen, DiagnoCure, Diagnomics, Diagnoplex, Diagnostica Longwood, Diagnostic International Distribution, Diagnostic Oncology Contract Research Organization, Diagnovus, DiA Imaging Analysis, DiaLine, DiamiR, DIAN Diagnostics, Diannei Biotechnology, Diaprost, Diasend, DiaSorin, DIAsource ImmunoAssays, Diassess, Diasys Diagnostics Systems, Diatech Pharmacogenetics, Diatherix, Diaxonhit, DICOM Grid, Dicom Systems, DigiPath Solutions, Digisonics, Dilon Diagnostics, Dimerix Biosciences, Diomics, Disior, DKSH, DNA Electronics, DNA Link, DNAmito, DNAnexus, DnaNudge, DNA Software, Domainex, Dominion Diagnostics, Doping Control Center, Draeger Safety Diagnostics, Draper Laboratories, Drawbridge Health, DreaMed Diabetes, Dr Ho Now Health Products, Dr Risch, Duchenne UK, Duke-NUS Graduate Medical School Singapore, Duke Medical, Duke University, Duke University Medical Center, Duquesne University, DxM Diagnostico Molecular, DxTerity, Dynasty Castle Investments, DySIS Medical, Dystonia Medical Research Foundation, E.I. Medical Imaging, E25Bio, EarlySense, Eastern Ontario Regional Laboratory Association, Easton Pharmaceuticals, eCardio Diagnostics, Eccrine Systems, Echosens, Eckerd College, Eckert & Ziegler, Ecole Polytechnique Federale de Lausanne, Ecolog International, Edan Diagnostics, Edan Instruments, Eddingpharm, Edico Genome, Edinburgh Molecular Imaging, EDP Biotech, Edwards Lifesciences, Efferent Labs, Eigen, Eiken Chemical, Eisai, Eisai S.A.S, eKare, EKF Diagnostics, EKF Diagnostics (Germany), Eko, Eldan, Electrical Geodesics, Elekta, Elesta, Elevation Oncology, Eleven Biotherapeutics, Eli Lilly, Elithea Sciences, Ellume, ElMindA, Elucid Bioimaging, Elucigene, Eluthia, Embryo Ventures, EMC, EMD Millipore, Emerald Organic Growth, Emergency Medicine Foundation, Emmes, EMM Life Science, Emory University, Empatica, Empire Genomics, Empowered Diagnostics, EMTensor, Emulate, Enable Biosciences, Ender Diagnostics, Endocanna Health, EndoChoice, Endotronix, ENDRA Life Sciences, Enigma Biomedical, Enigma Diagnostics, ENSCO, Entellus Medical, Enterome Bioscience, Enzo Clinical Labs, Enzyre, Enzyvant Science, EOS Imaging, EpiBone, Epica Medical Innovations, EpicGenetics, Epicore Biosystems, Epic Sciences, Epigenomics, Epimune Diagnostics, Epivax, Epredia, Epsilon, Erasmus University Medical Center, ERBA Diagnostics, Erisyon, ERT, Esaote, Essen University Hospital, Ethicon Endo-Surgery, Ethos Research & Development, Ethos Veterinary Health, Eureka Eurostars, Eurobio, EuroClone, Eurofins Genomics, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Commission, European Health Centre Innovation, European Infrastructure for Translational Medicine, European Molecular Genetics Quality Network, European Organization for Research and Treatment of Cancer, European Prevention Center, European Prevention of Alzheimer’s dementia Initiative (EPAD), European Union, Eutropics Pharmaceuticals, EV Biologics, Event Cardio Group, EverlyWell, Everything Genetic, Evexia Diagnostics, Evogen, Evotec, Exact Imaging, Exact Sciences, Exagen Diagnostics, Exalenz Bioscience, Excella, Exosome, Exosome Diagnostics, Exosome Sciences, ExoStat Medical, Expedeon, Expesicor, Exponent Private Equity, Expression Analysis, ExSeed, Eyesense, Ez Sleep Technologies, FABPulous, Fabric Genomics, Facebook, Factorial Diagnostics, Faes Farma, Falco, Fannin, Faron Pharmaceuticals, Fast-Track Diagnostics, FASTVet, Federal Ministry of Education and Research (BMBF), FedMed, FEI, Feinstein Institute for Medical Research, Felkasta JSC, Ferring Pharmaceuticals, FetoLumina Technologies, Fianostics, FibriCheck, Finnish Funding Agency for Technology and Innovation (TEKES), Finnish Institute for Health and Welfare, Fio, First Check Diagnostics, First Genetics JCS, Fisher Healthcare, FitBit, Five Prime Therapeutics, Flagship Biosciences, Fleming Fund, Flemish agency for Innovation by Science and Technology, FlexDex, Flirtey, Florida International University, FlowMetric Life Sciences, Fluidigm, Fluigent, Fluoresentric, Fluxergy, Fluxion Biosciences, FLX Bio, FNApath, Focal Healthcare, Fondation Cancer, Fondatioun Kriibskrank Kanner, Food and Drug Administration (FDA), FORMA Therapeutics, Forsitech, Fortelinea Software Systems, Fortified Provider Network, Fosun Diagnostics, Fosun Pharmaceutical, Foundation for Innovative New Diagnostics, Foundation Medicine, Fox Chase Cancer Center, Frankenman Medical Equipment, Fraunhofer Institute for Microelectronic Circuits and Systems, Fred Hutchinson Cancer Research Center, Freenome, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, frog, Fscan, Fudan University, Fujifilm, Fujifilm medical systems, FUJIFILM SonoSite, Fujirebio Diagnostics, Fukuda Denshi, Fulcrum Therapeutics, Fulgent Genetics, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Genomics, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, G42 Healthcare, Galapagos, Galaxy Health Network, Galectin Therapeutics, Galmed Pharmaceuticals, Gamma Medica, Garmatex Technologies, Garvan Institute of Medical Research, Gastrologix, GBS, GCS Sesan, Gedeon Richter, GE Global Research, GE Healthcare, Geisinger Medical Center, GEMCO Medical, Gemelli Biotech, Gemini Therapeutics, Gen-Probe, GENALICE, Genalyte, GenCell Biosystems, Genclis, Gencove, Genecast, GeneCentric Therapeutics, GeneDX, GeneInsight, Genelabs Technologies, GeneNews, Genentech, GeneOcean Biotech, GenePeeks, GenePOC, General Electric (GE), GeneSeek, Geneseeq, GenesisCare, GeneThera, Genetic Analysis, Genetic Technologies, Genetron Health, Geneva University Hospitals, Genewell Biotechnology, Genewiz, Genfit, Genmab, Genoma, Genomac Research Institute, Genomas, Genome Canada, GenomeDx, Genome Institute of Singapore, Genomeon, Genome Prairie, GenomeSmart, Genomic Health, Genomics England, Genomic Testing Cooperative, Genomind, Genomoncology, Genoptix, Genosity, Genotests, Genova Diagnostics, GenScript Biotech, GenSignia IP, GensKey Medical Technology, Gentag, GenTegra, Gentex, Genticel, Geo-Med, George Mason University, Georgetown University, George Washington University, Georgia Institute of Technology, German Cancer Research Center, German Federal Ministry of Education and Research, Gestalt Diagnostics, Gestvision, GE Ventures, GHR Foundation, Gibraltar Brothers and Associates, Gibson Oncology, Gilead Sciences, GIMDx, Ginkgo BioWorks, GI OnDEMAND, GI Reviewers, GlaxoSmithKline, GLG Pharma, Glide, Global Biological Standards Institute, Global Cancer Diagnostics, Global Discovery Biosciences, Global Dx, Global Genomics Group, Global Good Fund, Global Medical Solutions, Global WholeHealth Partners, Globavir Biosciences, Glooko, Gloval Specimen Solutions, Glycotest, GlySens, Glytec, Glythera, gMed Canada, GNA Biosolutions, Gnomegen, GNS Healthcare, GNYHA Services, Goffin Molecular Technologies, Golden Valley Development, Golden Vine International, Gold Standard Diagnostics, Good Start Genetics, Goodwin Biotechnology, Google, Gotect Diagnostic, Government of Canada, Government Scientific Source, Grail, GrandOmics Biosciences, Grand River Aseptic Manufacturing, Gravity Diagnostics, Great Basin Scientific, Greater New York Hospital Association, Green Cross Medical Science, Greenfield Global, Greiner Bio-One, Group K Diagnostics, Group Vida, Grupo Ferrer, GSK Consumer Healthcare, GTP Technology, Guangzhou Institute of Respiratory Disease, Guangzhou Pharmaceutical Group, Guardant Health, Guerbet, Guided Therapeutics, Guided Therapy Systems, GuoMinXinHe Investment Fund, Gyros Protein Technologies, Hackensack Meridian Health, Hadassah Medical Center, Hai Kang Life, Hainan Savy Akers Biosciences, Hainan Savy Investment Management, Hainan Sinotau Pharmaceutical, HalioDx, HALO Diagnostics, Halo Dx, Halozyme Therapeutics, Halt Medical, Hamilton Health Sciences, Hamilton Robotics, Hangzhou Tigermed Consulting, Hansen Medical, Hartford HealthCare, Harvard Bioscience, Harvard Medical School, Harvard Pilgrim Health Care, Harvard University, Hawaii Medical, Healgen Scientific, HEALTH Biomed, Health Canada, Healthcare 21, HealthCare Konnect, Health Diagnostics Laboratory, Healthimation, Health Logic Interactive, HealthLytix, Healthmark Industries, HealthMyne, Health Network Laboratories, Healthsense, HealthSpot, HealthTrust, HealthTrust Purchasing Group, Healthvana, Heartflow, HeartGenetics, HeartHero, Heart Imaging Technologies, HeartIT, HeartScore, Heat Biologics, Hebrew University of Jerusalem, Helio Health, Helix, Helix2, HelixBind, Helomics, HemaTone, Hememics Biotechnologies, Hemogenomics Pharma, HemoShear, Henan Province People's Hospital, Hengrui Therapeutics, Henlius Biotech, Hennepin County Medical Center, Henry Ford Health System, Henry M. Jackson Foundation, Henry Schein, Hepregen, Heritage Valley Health System, Herzog Surgical, Hesperos, HiberCell, HiberGene Diagnostics, High Desert Heart Institute, Highmark Blue Shield, HistoCyte Laboratories, HistoIndex, Hitachi, Hitachi Aloka Medical, Hitachi Chemical, Hitachi High-Technologies Corporation, Hitachi Medical Systems Europe, HMicro, HMNC Brain Health, Hoag Memorial Hospital Presbyterian, Hob Diagnostics, Holberg EEG, Hologic, Honeywell, Hong Kong Polytechnic University, Hoowaki, Horizon 2020, Horizon Blue Cross Blue Shield, Horizon Discovery, Horizon Therapeutics, Hospital Fondation Adolphe de Rothschild, Hospital of University of Strasbourg, Hospital Services, Hoth Therapeutics, Houston Healthcare, HOYA Corporation, HOYA Vision Care, HP, HR Pharmaceuticals, HTG Molecular Diagnostics, Huakang Biomedical, Huami, Huawei, Hubrecht Organoid Technology, Hudson Robotics, Humana, Human Longevity, HuminTec, Hummingbird Diagnostics, Hunan Xing Hang Rui Kang Bio-Technologies, Huntsman Cancer Institute, Huvitz, Hvidovre Hospital, hVIVO, Hybridyne Imaging Technologies, Hygea Precision Medicine, Hy Laboratories, Hyperfine Research, I-MED Pharma, i-Optics, IBA, IBA Molecular Imaging, Ibex Medical Analytics, iBIO Institute’s PROPEL Center, IBL America, IBM, IBM Watson Health, iCAD, Icagen, Icahn School of Medicine at Mount Sinai, iCardiac Technologies, Ichor Blood Services, Icometrix, Icon, ICT Health, Idaho Urologic Institute, IDbyDNA, IDEAS DWC, Idengene, IDenta, IdentifySensors Biologics, Idera Pharmaceuticals, IDIBELL, IDS, IDx, Ifa Systems, iGenomix, ii Ventures, Illumina, ImaBiotech, Image Analysis, ImageIQ, ImageMover, Image Stream Medical, ImaginAb, Imaging Associates, Imagin Medical, Imago Systems, Imalogix, Imanis Life Sciences, Imanova, Imaware, Imbio, IMD Companies, Imec, Imegen, IMI, IMIDomics, ImmersiveTouch, Immucor, ImmuMetrix, ImmunArray, Immunexpress, ImmunID Technologies, ImmunoCellular Therapeutics, Immuno Diagnostic, ImmunoGen, ImmunoPrecise Antibodies, Immunovia, iMotions, ImpediMed, Imperial College London, Imperial Innovations, Imricor Medical Systems, IMRIS, INanoBio, IncellDx, Incyte, Independent Medical Coop, InDevR, Indiana University, Indica Labs, Indigo Biosciences, Indivumed, Infectolab Americas, Infinity BiologiX, Infinity Group, Inflammatix, Inflammatory Breast Cancer Research Foundation, Inflazome, InfoBionic, Informed Data Systems, Inform Genomics, Infrared Cameras, InfraReDx, InfraScan, InGen BioSciences, Ingenza, inHEART, Inhibrx, Inivata, InnaVirVax, InnerOptic Technology, Innosieve Diagnostics, InnoTech Precision Medicine, Innova Biosciences, Innovate BC, Innovate UK, Innovation Skane, Innovation Zed, Innovative Diagnostic Laboratory, Innovo, Innovus Pharmaceuticals, Inotrem, Inova Health System, Inova Labs, Inova Translational Medicine Institute, Inovio Pharmaceuticals, Inscopix, Inserm, Inserm Transfert, InSightec, Insight Genetics, InSphero, InstaNatural, InstantLabs, Institut Català d'Oncologia, Institut Curie, Institut de Radiofarmacia Aplicada de Barcelona, Institute for Bioscience and Biotechnology Research, Institute for Genome Statistics and Bioinformatics, Institute for Global Food Security, Institute for Systems Biology, Institute of Biophysics, Institute of Cancer Research, Institute of Human Genetics, Institute of Molecular Biology of Paraná (IBMP), Institut Gustave Roussy, Instituto Diagnostico Varelli, Institut Pasteur, Instrumentation Laboratory, Insulet, Intalere, IntegraGen, Integrated Biobank of Luxembourg, Integrated BioTherapeutics, Integrated Computer Solutions, Integrated Diagnostics, Integrated DNA Technologies, Integrity Applications, Intelerad Medical Systems, Intelligence Advanced Research Projects Activity (IARPA), Intensity Therapeutics, Interlab INTERAUTOMATIKA UAB, Interleukin Genetics, Intermountain Healthcare, International Myeloma Foundation, Interpace Diagnostics, Interpace Diagnostics Group, Interscope, InterSystems, Intezyne, Intra Globus Biosystems, Intrinsic LifeSciences, IntroMedic, Invenio Imaging, Invenra, inVentiv Health, inviCRO, Invitae, InVivoScribe, Ionis Pharmaceuticals, ION Solutions, Ion Torrent, IP Biotech, IPMD, IQ-AI, iQ Group, iRemedy Healthcare Companies, iRhythm Technology, IronHealth, Iron Horse Diagnostics, Ironwood Pharmaceuticals, IRX Therapeutics, iSchemaView, ISIS Innovation, Isologic Innovative Radiopharmaceuticals, IsoPlexis, ISOThrive, Isotope Technologies Garching, Isotopia Molecular Imaging, Istituto Diagnostico Varelli, Itamar Medical, ITEL, Item, ITEM Medical Technologies, Iterative Scopes, iThera Medical, ITM Isotopen Technologien, ITOCO, Itus, IviGen, iVu Imaging, IXICO, Jai Capital, JAJ International, James S. McDonnell Foundation, Jan Medical, Janssen-Cilag, Janssen Biotech, Janssen Diagnostics, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Jazz Pharmaceuticals, Jeffrey Modell Foundation, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Egens Biotechnology, Jiangsu Hengrui Medicine, JNC Medical, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Johnson & Johnson Vision, John Wayne Cancer Institute, Joint Venture Partner Group, JTS Health Partners, Jubilant DraxImage, Jubilant Radiopharma, Juno Therapeutics, Kailos Genetics, Kaiser Foundation Research Institute, Kaiser Permanente, Kalgene Pharmaceuticals, Kansas University Medical Center (KUMC), Kantaro Biosciences, Kanteron Systems, Kapa Biosystems, Karius, Karolinska Institute, Karolinska University Hospital, KDx Diagnostics, Keck School of Medicine of USC, Keio Gijuku University, Kennedy Health System, Kent Imaging, Kessler Foundation, KEW, Kim & Friends, Kindstar Globalgene Technology, KineMed, KingMed Diagnostics, Kings College London, Kite Pharma, Kiyatec, KMG International, Knight Cancer Institute, Knight Diagnostic Laboratories, Know Labs, Konica Minolta, Konica Minolta Precision Medicine, Kore, Korea Pharma, KromaTiD, KUB Technologies, Kurabo, Kura Oncology, L1 Enterprises, L1 Systems, Lab21, Labcyte, Labgene Scientific, Lab Genomics, Laboratorios LETI, Laboratory Corporation of America, Laboratory Supply Company (LABSCO), LabPro, Labrador Technologies, LabStyle Innovations, Laerdal Medical, La Jolla Institute for Allergy & Immunology, LamdaGen, Lantheus Holding, Lantheus Medical Imaging, Lark Technologies, Launch Diagnostics, Laurel Bridge Software, LCS Therapeutics, LDR Holding, Lee's Pharmaceutical, Lee Moffitt Cancer Center, Legacy Of Angels Foundation, Lehigh University, Leica Biosystems, Leica Microsystems, Leicester University, Leiden University, Leidos Holdings, Leinco Technologies, LeMaitre Vascular, LEO Pharma, Les Laboratoires Servier, LexaGene, Lexent Bio, Lexogen, LGC, LI-COR Biosciences, Lieber Institute, LifeCaring Technologies, LifeCell, LifeCodexx, Life Image, LifeLabs Medical Laboratory Services, Lifeloc Technologies, LifeOmic, LifeScan, LifeSensors, Life Technologies Corporation, LifeWatch Services, LifeX Ventures, LightDeck Therapeutics, Lighthouse Imaging, Lightpoint Medical, Li Ka Shing Foundation, Lineagen, LineaRx, Link Pharmaceuticals, Link Technologies, LI Path, LivaNova, Liverpool School of Tropical Medicine...


For the full list of companies email us on


Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.